(Q51346088)

English

Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities--the BEGAMI study.

scientific article published on 14 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities--the BEGAMI study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

1 reference

ChEBI release 2020-05-28

acute coronary syndrome

1 reference

based on heuristic

Kerstin Brismar

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

3

object named as

S Efendic

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

author name string

C Hage

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

P Lundman

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

L Rydén

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

L Mellbin

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

language of work or name

0 references

publication date

14 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

273

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

410-421

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Pathophysiology of prediabetes

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Preservation of β-cell function: the key to diabetes prevention

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Effect of sitagliptin plus metformin on β-cell function, islet integrity and islet gene expression in Zucker diabetic fatty rats.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Sitagliptin: a review

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12032

21 January 2018

Identifiers

10.1111/JOIM.12032

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23331339

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51346088&oldid=1622299677"